HeartFlow announced today that John Farquhar has been appointed as the company’s president and CEO, effective today. Farquhar, a former Medtronic executive, was appointed as COO of HeartFlow in August 2021 and has served as the company’s president and a member of the board since Jan. 1, 2022. According to a news release, co-founder and […]
HeartFlow
HeartFlow SPAC deal is called off
HeartFlow and a special purpose acquisition company called Longview Acquisition Corp. have called off merger plans that would have taken the cardiac test company public. HeartFlow, in a news release out this evening, described the move as a mutual decision — a “result of current unfavorable market conditions.” Stock markets in the U.S. have been […]
HeartFlow appoints former Medtronic executive as COO
HeartFlow today announced that it has appointed John Farquhar as chief operating officer, effective immediately. Farquhar will be responsible for executing the strategic vision of the Redwood City, Calif.–based company — developer of the non-invasive HeartFlow FFRCT analysis. “We are thrilled to add an executive of John’s caliber and accomplishments to the HeartFlow leadership team,” […]
MedTech 100 roundup: Industry shatters all-time best with remarkable rise
The medtech industry’s steady growth provided optimism in recent weeks, but an unforeseen leap sees it hitting new heights now. MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (July 16) at 145.88 points, a remarkable 27.1% rise week-over-week, registering by far the greatest increase the […]
HeartFlow to go public in $2.8B SPAC merger
HeartFlow today said that it will go public by merging with a SPAC called Longview Acquisition Corp. The merger is valued at $2.4 billion plus an estimated $400 million in cash after closing. The transaction is expected to deliver up to $599 million of gross proceeds to HeartFlow to accelerate the growth of its noninvasive, […]
FDA clears HeartFlow Planner
HeartFlow said yesterday that it won FDA clearance for its Planner tool for coronary artery disease intervention. The Redwood City, Calif.-based company developed FFRct, which works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing changes in flow across coronary lesions. The Planner virtual […]
HeartFlow adds another $65m
HeartFlow added another $65 million to its coffers for the heart function analysis it developed. Redwood City, Calif.-based HeartFlow, which developed the FFRct fractional flow reserve analysis, said it hopes to raise another $35 million in the equity round. Nine unnamed investors participated, with the first sale occurring June 11,HeartFlow said in a regulatory filing. […]
HeartFlow taps ex-Beaver-Visitec CEO Mead as chief exec | Personnel Moves – May 28, 2019
HeartFlow said today that it named former Beaver-Visitec prez & CEO Dana Mead, Jr., as its new president and CEO, replacing current prez & CEO Dr. John Stevens, who will continue to serve on the board as chair. Prior to joining Beaver-Visitec, Mead served as a strategic advisor and partner in Kleiner Perkins Caufield & […]
Artificial intelligence and medicine: Is it overhyped?
Artificial intelligence raises exciting possibilities for healthcare, but are companies promising more than they can deliver? AI could possibly fuel the future of medtech, enabling such thrilling innovations as implanted devices that instantly react to minute changes, software that can identify the best treatment options for individuals facing life-threatening conditions and fully-functioning autonomous surgical systems. […]
HeartFlow publishes findings from consumer survey
HeartFlow this week published the findings of a 1,500-person consumer survey, reporting that just 29% of respondents knew that heart disease is the No. 1 cause of death among adults in the U.S. Half of the survey’s participants said that breast cancer is the leading cause of death among women, rather than heart disease. “We […]
HeartFlow wins Japanese reimbursement for FFRct analysis
HeartFlow said yesterday that it won reimbursement coverage from the Japanese Ministry of Health, Labor and Welfare for its HeartFlow FFRct fractional flow reserve analysis. The Redwood City, Calif.-based company said that it has already received approval from the Japanese Pharmaceuticals and Medical Devices Agency, and that reimbursement will go into effect beginning on December 1. […]
